ABSTRACT

Objective: To evaluate the prescription pattern in CKD patients undergoing dialysis, to study the impact of polypharmacy and to study co-morbidities associated with CKD patients. CKD has been recognized as a leading public health problem worldwide. Patients under dialysis are under higher risk of many comorbidities. Methodology: A retrospective observational study was carried out in a tertiary care hospital for a period of 6 months in which data from January 2019 - December 2021 were collected from the Nephrology Department. Result: Out of 225 CKD patients undergoing hemodialysis, 152 were males and 73 were females. The most prescribed drug in the study population was cardiovascular drugs (44%). This was followed by Hematopoietic agents (19%). The most common comorbid condition associated with these patients was hypertension (97.55%) followed by anemia (94.22%). An average of 11 drugs were prescribed per prescription which showed polypharmacy and drug interactions were found to be about 26.19%. Conclusion: Dialysis among chronic kidney disease patients is increasing in the present scenario. Appropriate drug selection is important in order to avoid unwanted drug effects. This study was an attempt to study the prescribing pattern in patients undergoing hemodialysis Keywords: Chronic kidney disease, hemodialysis, prescription pattern, comorbidities, polypharmacy
Publication date: 01/01/2025

https://ijbpas.com/pdf/2025/January/MS_IJBPAS_2025_8615.pdf

Download PDF
https://doi.org/10.31032/IJBPAS/2025/14.1.8615